Mokhtarani, M., Diaz, G., Rhead, W., Lichter-Konecki, U., Bartley, J., Feigenbaum, A., . . . Scharschmidt, B. (2012). Urinary Phenylacetylglutamine as Dosing Biomarker for Patients with Urea Cycle Disorders.
Chicago-stil citatMokhtarani, M., et al. Urinary Phenylacetylglutamine As Dosing Biomarker for Patients With Urea Cycle Disorders. 2012.
MLA-referensMokhtarani, M., et al. Urinary Phenylacetylglutamine As Dosing Biomarker for Patients With Urea Cycle Disorders. 2012.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.